Johnson & Johnson Proposes $5.5 Billion to Resolve Talc Claims
WHO:
Al Jazeera - Johnson & Johnson (J&J) is the company involved in the lawsuits.
Al Jazeera - Erik Haas is J&J’s litigation head.
Al Jazeera - Lawyers representing the plaintiffs are involved in the settlement discussions.
WHAT:
Fox Business - Johnson & Johnson's proposed settlement could ultimately reach $7 billion or more, as it does not cap the total payout and assigns specific values to qualifying ovarian cancer claims.
Fox Business - The settlement will be paid out within 18 months instead of being spread out over more than a decade.
ABC News - Johnson & Johnson will make an initial payment of no more than $3 billion in 2027, with further payments due in 2028.
ABC News - Johnson & Johnson will make an initial payment of no more than $3 billion next year as part of the proposed settlement.
ABC News - Johnson & Johnson has no additional payments due until 2028.
ABC News - A federal judge last week ordered plaintiffs in the case against Johnson & Johnson to show why the remaining pending talc claims should not be dismissed after their witnesses could not provide a direct link between the company's product and cancer.
ABC News - Erik Haas stated, “While we are confident the company would have ultimately prevailed with further litigation, as it has in the vast majority of cases tried to date, this resolution allows the company to put this matter behind it and remain focused on its mission to develop medicines and devices that save lives.”
ABC News - Johnson & Johnson will make an initial payment of no more than $3 billion next year as part of the proposed settlement.
ABC News - Johnson & Johnson has no additional payments due until 2028.
ABC News - A U.S. bankruptcy court judge denied a $9 billion settlement proposed by company subsidiary Red River Talc last year.
ABC News - Erik Haas stated, “The Court’s order placed plaintiffs in an untenable position of having to present specific causation evidence to maintain their claims that does not exist."
ABC News - Johnson & Johnson previously settled about 95% of filed lawsuits for mesothelioma, all state consumer protection claims, and all talc-supplier disputes.
Al Jazeera - Johnson & Johnson announced that the proposed settlement of $5.5 billion aims to resolve tens of thousands of lawsuits alleging its talc products caused ovarian cancer.
Al Jazeera - The settlement agreement will only be finalized if accepted by 95 percent of the claimants in state or federal courts.
Al Jazeera - In 2016, a US jury ordered J&J to pay $72 million to the family of a woman who died of ovarian cancer, marking the first such case related to the use of talc in the country.
Al Jazeera - The UK case alleges that J&J knew that its talc could cause cancers, chiefly ovarian and mesothelioma, but continued to sell the product, a claim the company denies.
Al Jazeera - Johnson & Johnson has proposed a settlement of $5.5 billion to resolve approximately 69,000 lawsuits in the United States.
Al Jazeera - The settlement covers 99.75 percent of outstanding talc-related cases in the US.
Al Jazeera - The settlement will be finalized only if accepted by 95 percent of the claimants in state or federal courts.
Al Jazeera - The UK case against J&J involves more than 7,000 potential claimants and is the largest product liability case in UK history.
WHERE:
Al Jazeera - The lawsuits are filed in US federal and state courts.
Al Jazeera - The UK case is being adjudicated in the UK High Court.
WHEN:
Al Jazeera - The UK case was filed in October 2025.
Al Jazeera - J&J stopped selling talc-based baby powder in the US in 2020 and worldwide in 2023.
WHY:
Fox Business - The new settlement only applies to existing claims and does not address future lawsuits, allowing more money to be available for current plaintiffs.
Al Jazeera - The lawsuits allege that J&J's talc-based baby powder caused ovarian cancer, with claims multiplying since a 2016 jury ordered J&J to pay $72 million to a family in a related case.
Al Jazeera - The lawsuits allege that J&J's talc-based baby powder caused ovarian cancer.
Al Jazeera - The World Health Organization classified talc as “probably carcinogenic to humans” in 2024.
Al Jazeera - J&J maintains that there is no evidence that talc causes cancer.
HOW:
ABC News - Shares of the New Brunswick, New Jersey-based company rose more than 2% before the market open on Tuesday.
Al Jazeera - Lawyers representing the plaintiffs welcomed the settlement as a good resolution to a decade-long court battle.
Al Jazeera - The settlement agreement allows J&J to “put this matter behind it,” according to Erik Haas.
(UPDATED July 28, 2026 19:26 UTC)
Johnson & Johnson's proposed settlement could exceed $7 billion, as it assigns specific values to qualifying ovarian cancer claims without capping the total payout. The company plans to make an initial payment of up to $3 billion in 2027, with additional payments scheduled for 2028, and the entire settlement will be paid out within 18 months rather than over a decade. This new settlement only covers existing claims, ensuring that more funds are available for current plaintiffs while leaving future lawsuits unaddressed.
--
(UPDATED July 28, 2026 18:24 UTC)
Johnson & Johnson will make an initial payment of no more than $3 billion next year as part of a proposed settlement, with no additional payments due until 2028. A federal judge recently ordered plaintiffs in the case against the company to explain why the remaining talc claims should not be dismissed, as witnesses failed to establish a direct link between the product and cancer. Following this news, shares of the New Brunswick, New Jersey-based company rose more than 2% before the market opened.
--
(UPDATED July 28, 2026 14:47 UTC)
Johnson & Johnson is set to make an initial payment of no more than $3 billion next year as part of a proposed settlement, with no additional payments due until 2028. A U.S. bankruptcy court judge recently denied a $9 billion settlement proposed by the company's subsidiary, Red River Talc, while Erik Haas commented that the court's order has left plaintiffs in a difficult position regarding the evidence needed to support their claims. Previously, Johnson & Johnson settled approximately 95% of filed lawsuits related to mesothelioma, along with all state consumer protection claims and disputes with talc suppliers.
--
(UPDATED July 28, 2026 10:52 UTC)
Johnson & Johnson has announced a proposed settlement of $5.5 billion to resolve tens of thousands of lawsuits claiming that its talc products caused ovarian cancer. This settlement will only be finalized if it receives acceptance from 95 percent of the claimants in state or federal courts. The lawsuits have surged since a 2016 jury ordered Johnson & Johnson to pay $72 million to a family in a related case.
--
(UPDATED July 28, 2026 07:54 UTC)
A UK court has ruled against Johnson & Johnson in a case alleging that the company knowingly sold talc products that could cause cancers, including ovarian cancer and mesothelioma, a claim the company denies. This ruling follows a significant 2016 US jury decision that ordered J&J to pay $72 million to the family of a woman who died from ovarian cancer linked to talc use. Lawyers for the plaintiffs have expressed satisfaction with the settlement, viewing it as a positive resolution to a decade-long legal struggle.
--
(UPDATED July 28, 2026 06:48 UTC)
Johnson & Johnson has proposed a settlement of $5.5 billion to resolve approximately 69,000 lawsuits in the United States, which covers 99.75 percent of outstanding talc-related cases. The settlement will only be finalized if accepted by 95 percent of the claimants in state or federal courts, while a separate case in the UK, involving more than 7,000 potential claimants, is currently being adjudicated in the UK High Court. J&J's litigation head, Erik Haas, stated that the settlement agreement allows the company to “put this matter behind it.”